Patents by Inventor Bhaskar C. Das

Bhaskar C. Das has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8581005
    Abstract: The present invention relates to inhibitors of mitochondria-associated, granulocyte-macrophage colony stimulating factor signaling molecule (Magmas), and related compositions and uses thereof.
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: November 12, 2013
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Paul Jubinsky, Bhaskar C. Das, Mary K. Short
  • Patent number: 8460635
    Abstract: Synthetic peptidomimetic derivatives and phenyl group derivatives of Fenretinide (4-HPR) are disclosed, as are their uses as therapeutic, diagnostic and imaging agents for cancer and other diseases.
    Type: Grant
    Filed: March 11, 2009
    Date of Patent: June 11, 2013
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Ganjam V. Kalpana, Bhaskar C. Das
  • Publication number: 20110236308
    Abstract: The present invention relates generally to chelation compounds, radionuclide metal chelate compounds, i.e., complexes, and radiolabeled targeting moieties, i.e., conjugates, formed therefrom, and methods of using these compounds, complexes and conjugates for diagnostic and therapeutic purposes. This invention is more particularly related to aryl bidentate isonitrile metal complexes generated by a chemical interaction of a metal salt oxide or weak complex of the metal with aryl isonitrile bidentate ligands.
    Type: Application
    Filed: April 17, 2007
    Publication date: September 29, 2011
    Applicant: The General Hospital Corporation
    Inventors: David R. Elmaleh, Timothy M. Shoup, Alan J. Fischman, Bhaskar C. Das
  • Publication number: 20110105522
    Abstract: The application discloses ketoconazole derivatives that are antagonists of the human pregnane X receptor (PXR), methods of preparing the derivatives, uses of the derivatives with drug therapy, and methods of inhibiting tumor cell proliferation and multidrug resistance using inhibitors of PXR.
    Type: Application
    Filed: January 27, 2009
    Publication date: May 5, 2011
    Inventors: Sridhar Mani, Bhaskar C. Das
  • Publication number: 20110091383
    Abstract: Synthetic peptidomimetic derivatives and phenyl group derivatives of Fenretinide (4-HPR) are disclosed, as are their uses as therapeutic, diagnostic and imaging agents for cancer and other diseases.
    Type: Application
    Filed: March 11, 2009
    Publication date: April 21, 2011
    Inventors: Ganjam V. Kalpana, Bhaskar C. Das